Nowadays, over 100 types of cancers affect humans, the cancer treatments will provide a higher survival rate and improve the life quality

Recently developed cancer immunotherapy is not effective for breast cancer treatment because of the immuno-suppressive tumour micro-environment. By understanding the complicated tumour micro-environment, we are developing innovative materials and strategies for advanced cancer therapy and immunotherapy. Our strategies have the potential to reduce side-effects and the overall cost in cancer treatment, which is beneficial for reducing the burden on patients and improving their quality of life.

 

Project members

Researchers

Dr Yannan Yang

Postdoctoral Research Fellow
Yu Group

Dr Jie Tang

NHMRC Emerging Leadership Fellow
Yu Group

Shevanuja Theivendran

Postdoctoral Research Fellow
Yu Group

Dr Zan Dai

Post Doctoral Research Fellow
Yu Group